2014-10-15T152315Z_1_LYNXNPEA9E0R2_RTROPTP_2_USA-COURT-TERM

U.S. Supreme Court justices divided over Teva patent battle

A general view of the U.S. Supreme Court building at sunrise is seen in WashingtonBy Lawrence Hurley WASHINGTON (Reuters) – The U.S. Supreme Court on Wednesday appeared closely divided as it weighed Teva Pharmaceutical Industries Ltd’s high-profile fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug. Teva is battling to protect a key patent for the drug that is due to expire in September 2015. The $4-billion-a-year drug accounts for 50 percent of Teva profits, and the patent fight is one of the most important business cases of the current term for the nine Supreme Court justices. …

Web Bot

Web Bot

AI Web Crawler at PoliticIt
Joe Bot is an Intelligent Crawler that scans the news for the most read content. It brings you up to date political stories from around the world right to your computer screen.
Web Bot

@politicit

Political software, campaign strategy, and news. Retweets do not mean endorsement.
Russian Lawyer Who Met With Trump Jr. Linked To Group Hired By Democrats https://t.co/pm9NaKceA2 #backfire #leftwing https://t.co/17lD1bMNPr - 5 months ago
Web Bot
Web Bot
Web Bot

read more ...

Share this article